Submitted:
12 June 2024
Posted:
13 June 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Results

3. Discussion
4. Materials and Methods
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Schieber, M.; Chandel, N.S. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014, 24, 453–462. [Google Scholar] [CrossRef]
- Dubois-Deruy, E.; Peugnet, V.; Turkieh, A.; Pinet, F. Oxidative stress in cardiovascular diseases. Antioxidants (Basel). 2020, 9, 864. [Google Scholar] [CrossRef]
- Zhao, Y.; Ye, X.; Xiong, Z.; Ihsan, A.; Ares, I.; Martínez, M.; Lopez-Torres, B.; Martínez-Larrañaga, M.; Anadón, A.; Wang, X.; Martínez, M. Cancer metabolism: the Role of ROS in DNA damage and induction of apoptosis in cancer cells. Metabolites. 2023, 13, 796. [Google Scholar] [CrossRef]
- Singh, A.; Kukreti, R.; Saso, L.; Kukreti, S. Oxidative Stress: a key modulator in neurodegenerative diseases. Molecules. 2019, 24, 1583. [Google Scholar] [CrossRef]
- Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010, 4, 118–126. [Google Scholar] [CrossRef]
- Zaitsev, V.G.; Ostrovskii, O.V.; Zakrevskii, V.I. Classification of the direct-acting antioxidants based on a relationship between chemical structure and target. Еxperimental and clinical pharmacology. 2003, V. 66. № 4. p. 66-70.
- Matuz-Mares, D.; Riveros-Rosas, H.; Vilchis-Landeros, M.; Vázquez-Meza, H. Glutathione participation in the prevention of cardiovascular diseases. Antioxidants (Basel). 2021, 10, 1220. [Google Scholar] [CrossRef]
- Jain, A.; Kumar Mehra, N.; Nitin Kumar Swarnakar, N. Role of antioxidants for the treatment of cardiovascular diseases: challenges and opportunities. Current Pharmaceutical Design. 2015, 21. [Google Scholar] [CrossRef]
- Fujisawa, S.; Kadoma, Y. Kinetic studies of the radical-scavenging activity of ebselen, a seleno-organic compound. Anticancer Research. 2005, 25, 3989–3994. [Google Scholar]
- Casalbore, G.; Mastragostino, M.; Valcher, S. Electrochemical bromination of benzene, toluene and xylene in acetonitrile. J. Electroanal. Chem. 1978, V. 87, pp. 411-418, 87.
- Abullin, I.F.; Budnikov, G.K. Zavod. Lab., 1998, V. 64, pp. 1–12.
- Lapin, A.A. , MVI-001-44538054-07. Summarnaya antioksidantnaya aktivnost'. Metodika vypolneniya izmerenii na kulonometricheskom analizatore (MVI-001-44538054-07. Total Antioxidant Activity. Methods of Measurement on a Coulometric Analyzer). Zherdevka: OOO Kontsern Otechestvennye innovatsionnye tekhnologii. 2011. 35 p.
- Siggia, S. Instrumental methods of organic functional group analysis. Moscow. 1974, pp. 446.
- Weissbach, H.; Etiennea, F.; Hoshib, T.; Heinemann, S.H.; Lowtherd, W.T.; Matthewsd, B.; John, G.S.; Nathane, C.; Brotef, N. Peptide methionine sulfoxide reductase: Structure, mechanism of action, and biological function. Arch. Biochem. Biophys. 2002, 397, 172–178. [Google Scholar] [CrossRef]
- Yermolaieva, O.; Xu, R.; Schinstock, C.; Brot, N.; Weissbach, H.; Heinemann, S.H.; Hoshi, T. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. Proc. Natl. Acad. Sci. USA. 2004, 101, 1159–1164. [Google Scholar] [CrossRef]
- Ruan, H.; Tang, X.D.; Chen, M.-L.; Joiner, M.-L.; Sun, G.; Brot, N.; Weissbach, H.; Heinemann, S.H.; Iverson, L.; Wu, C.-F. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA. 2002, 99, 2748–2753. [Google Scholar] [CrossRef]
- Moskovitz, J.; Bar-Noy, S.; Williams, W.M.; Requena, J.; Berlett, B.S.; Stadtman, E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA. 2001, 98, 12920–12925. [Google Scholar] [CrossRef]
- Ziyatdinova, G.K. , Grigor’eva, L. V. & Budnikov, G.K. Coulometric determination of sulfur-containing amino acids using halogens as oxidizing titrants. J. Anal. Chem. 2007, 62, 1176–1179. [Google Scholar] [CrossRef]
- Böck, A.; Forchhammer, K.; Heider, J.; Leinfelder, W.; Sawers, G.; Veprek, B.; Zinoni, F. Selenocysteine: the 21st amino acid. Molecular Microbiology. 1991, 5, 515–520. [Google Scholar] [CrossRef]
- Bai, Y.; Wang, T.; Liu, Y.; Zheng, W. Electrochemical oxidation of selenocystine and selenomethionine. Colloids and Surfaces B: Biointerfaces. 2009, V.74, 150-153. [CrossRef]
- Paul, B.D.; Sbodio, J.I.; Snyder, S.H. Cysteine metabolism in neuronal redox homeostasis. Trends Pharmacol Sci. 2018, 39, 513–524. [Google Scholar] [CrossRef]
- Noda, T.; Iwakiri, R.; Fujimoto, K.; Rhoads, C.A.; Aw, T.Y. Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells. Cell Prolif. 2002, 35, 117–129. [Google Scholar] [CrossRef]
- Mereto, G.C.; Balestra, L.; Henriquet, F. Alveolar surfactant in lungs of operated patients after acetylcysteine treatment. Eur. J. Respir. Dis. 1980, V. 61, pp. 160-161.
- Vogel, A.I. Elementary practical organic chemistry. Part 3. Quantitative organic analysis 2nd edition, Longman group ltd. London, 1975, 840 p.
- Lavine, Т.F. The oxidation of cystine in non-aqueous media: study of the reactions of the disulfoxide of l-cystine, especially of its dismutative decompositions. 1936, V.113, I. 2, pp. 583–597. [CrossRef]
- Pálla, T.; Mirzahosseini, A.; Noszál, B. Properties of selenolate-diselenide redox equilibria in view of their thiolate-disulfide counterparts. Antioxidants. 2023, 12, 822. [Google Scholar] [CrossRef]
- Blinokhvatov, A.F. , 9-R-sim-nonahydro-10-oxa(chalcogene)anthracenes and salts of 9-R-sim-octahydro-10-oxonium (chalcogenonium) anthracene, Doctoral (Chem.) Dissertation, Saratov, 1993, 378 p.
- Poluboyarinov, P.A.; Elistratov, D.G.; Shvets, V.I. Metabolism and mechanism of toxicity of selenium-containing supplements used for optimizing human selenium status. Fine Chemical Technologies. 2019, 14, 5–24, (In Russ.). [Google Scholar] [CrossRef]
- Sies, H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic. Biol. Med. 1993, V. 14, p. 313-323. [CrossRef]
- Blinokhvatov, A.F.; Denisova, G.V.; Il’in, D.Yu. Selenv biosfere (Selenium in Biosphere), Blinokhvatov, A.F., Ed., Penza: Penzensk. S.-kh. Akad., 2001, 322 p.
- Poluboyarinov, P.A.; Kuznetsova, A.V.; Moiseeva, I.Y.; Mikulyak, N.I.; Kaplun, A.P. Induction of the antioxidant activity by selenium compounds in the Aspergillus niger mycelium // Bioorganičeskaâ himiâ. 2023, V. 49, pp. 523–536. [CrossRef]
- Chew, P.; Yuen, D.Y.; Stefanovic, N.; Pete, J.; Coughlan, M.T.; Jandeleit-Dahm, K.A.; Thomas, M.C.; Rosenfeldt, F.; Cooper, M.E.; de Haan, J.B. Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes. 2010, 59, 3198–3207. [Google Scholar] [CrossRef]
- Parnham, M.J.; Sies, H. The early research and development of ebselen. Biochem. Pharmacol. 2013, V. 86, 1248–1253. [Google Scholar] [CrossRef]
- Masumoto, H.; Hashimoto, K.; Nakaoka, M.; Hakusui, H. Metabolism of ebselen (DR-3305). Relation to the Antioxidant Activity. 1995, V.10, pp. 158-161.
- Bhabak, K.P.; Vernekar, A.A.; Jakka, S.R.; Roy, G.; Mugesh, G. Mechanistic investigations on the efficient catalytic decomposition of peroxynitrite by ebselen analogues. Org. Biomol. Chem., 2011, 9, 5193–5200. [Google Scholar] [CrossRef]
- Fujisawa, S.; Kadoma, Y. Kinetic studies of the radical-scavenging activity of ebselen, a seleno-organic compound. Anticancer research. 2005, 25, 3989–3994. [Google Scholar]
- Rusetskaya, N.Y.; Borodulin, V.B.; Sarattsev, A.V.; Borodulin, Y.V. Comparative antioxidant activity of selenoorganic compound diacetophenonyl selenid and it nitroderivative in organs and tissues of mice with various oxidoresistance. Basic research. 2013, No 4-1. pp. 125-129.
- Zhukov, O.I. 3-Chalcogenapentane-1,5-diones: synthesis and features of transformations. PhD thesis (Chem.) Dissertation, Saratov, 1997.
- Kharchenko, V.G.; Chalaya, S.N. Thiopyrans, thiopyryllium salts and related compounds. Saratov, 1987, 160 p.
- Demidov, A.A.; Dmitrienko, T.G. Sensitizers based on nanostructured selenium heterocycles and they applications in medicine. Modern problems of science and education. 2013, № 5, pp. 707–707.
- Minich, W.B. Selenium metabolism and biosynthesis of selenoproteins in the human body. Biochemistry (Mosc). 2022, 87, 102–168. [Google Scholar] [CrossRef]
- Zhao, H.; Xu, C.; Wang, T.; Liu, J. Biomimetic construction of artificial selenoenzymes. Biomimetics (Basel). 2023, 8, 54. [Google Scholar] [CrossRef]
- Muscoli, C.; Cuzzocrea, S.; Riley, D.P.; Zweier, J.L.; Thiemermann, C.; Wang, Z.Q.; Salvemini, D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol, 2003; 140, 445–460. [Google Scholar] [CrossRef]
- Vera, M.; Torramade-Moix, S.; Martin-Rodriguez, S.; Cases, A.; Cruzado, J.M.; Rivera, J.; Escolar, G.; Palomo, M.; Diaz-Ricart, M. Antioxidant and anti-inflammatory strategies based on the potentiation of glutathione peroxidase activity prevent endothelial dysfunction in chronic kidney disease. Cell Physiol Biochem. 2018, 51, 1287–1300. [Google Scholar] [CrossRef]
- Pálla, T.; Mirzahosseini, A.; Noszál, B. Properties of selenolate-diselenide redox equilibria in view of their thiolate-disulfide counterparts. Antioxidants (Basel). 2023, 12, 822. [Google Scholar] [CrossRef]
- Poluboyarinov, P.A.; Moiseeva, I.Ya.; Mikulyak, N.I.; Golubkina, N.А.; Kaplun, A.P. A new synthesis of cystine and sele-nocystine enanthiomers and their derivatives. ChemChemTech [Izv. Vyssh. Uchebn. Zaved. Khim. Khim. Tekhnol.]. 2022, V. 65, №2, pp. 19-29. [CrossRef]
- Poluboyarinov, P.A.; Aniskov, A.A. Analysis of ebselen using HPLC and NMR spectroscopy. Education and science in the modern world. Innovation. 2017; No 1, 73–80. [Google Scholar]

















| Ratio of the reagents Sec-Sec : BME/NAC |
Recovery (reduction) of Sec-Sec: BME/NAC, % | Кc Sec-Sec :BME / NAC |
| 1:1 | 20,3 / 11,8 | 0,1187 / 0,0126 |
| 1:2 | 28,2 / 17,9 | 0,0610 / 0,0104 |
| 1:3 | 37,4 / 22,0 | 0,0655 / 0,0084 |
| Introduced, microgram | Found, F = 1/6 | Found after reduction, microgram |
Regenerated, % |
| 10,0 | 9,487 | 8,746 8,979 9,101 |
92,2 94,6 95,9 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).